Mass tort intelligence · est. 2026

Stop guessing on drug viability.

One search surfaces every signal mass-tort attorneys need — FDA adverse events, MDL velocity, venue favorability, expert history — graded by evidence tier and cited to source.

DOSSIER · MDL-2973

Elmiron (Pentosan Polysulfate)

TIER A ✓
Adverse events
6,418
Active filings
2,147
Venue score
7.9
MDL filing velocity — 12 mo
AI synthesis ready · 14 sources cited · updated 2h ago

Built on the primary sources attorneys already trust

openFDA FAERSClinicalTrials.govDailyMedCourtListenerSEC EDGARJPMLFederal RegisterRxNavOrange BookEPACPSCopenFDA FAERSClinicalTrials.govDailyMedCourtListenerSEC EDGARJPMLFederal RegisterRxNavOrange BookEPACPSC
Why firms switch

Defensible intelligence, instantly

Real data, graded and cited — not a black box.

0+
Drugs & devices tracked
0
MDLs tracked
0
Primary data sources
A–D
Evidence tier on every claim
Live from the platform

The intelligence, in motion

These are the real charts PharmaVector produces — shown here with representative data. Each binds to a live output.

MDL filing velocity — top active dockets
Live
Filings across the highest-volume MDLs
Filings by venue
Where the cases are concentrated
Adverse-event signal
24-mo trend, representative
Top reported reactions
Most-reported reaction terms
Evidence tier mix
Distribution across screened claims
One platform, three jobs

Research · Monitor · Build

Research a drug

PharmaVector & ConsumerVector — type a name, get a cited viability picture across 12 views.

Monitor litigation

MDL Tracker, court feed, regulatory calendar, and watchlist alerts — the landscape, live.

🗂

Build the case

Expert witnesses, documents, intake, and the settlement calculator — turn intel into work product.

The defensibility engine

Every claim graded A–D

The trust mechanism no competitor has.

A

Primary-source verified

Direct FDA / court / regulatory evidence. Use with confidence.

B

Corroborated

Multiple secondary sources agree. Strong; verify specifics.

C

Reported

Single or preliminary source. Treat as a lead.

D

Unsupported

Lacks sourcing. Flagged, never relied on.

See it work

Watch the AI memo run

From one drug search to a cited, evidence-graded analytical memo — in real time.

Stop guessing. Start grading.

Run your first dossier free — a real, cited viability picture before you pay a cent.